Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Treatment of common variable immunodeficiency disorders (CVID) is based on replacement therapy using intravenous (i.v.) or subcutaneous (s.c.) immunoglobulin (Ig)G. Interindividual variation of IgG dose is common. A total of 380 CVID patients on stable IgG replacement from two prospective cohorts we...

Full description

Bibliographic Details
Main Authors:	Gouilleux-Gruart, V, Chapel, H, Chevret, S, Lucas, M, Malphettes, M, Fieschi, C, Patel, S, Boutboul, D, Marson, M, Gérard, L, Lee, M, Watier, H, Oksenhendler, E
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Efficiency of IgG Replacement Therapy in Patients with CVID : Correlations with Clinical Phenotype and Polymorphism of The Neonatal FC Receptor
by: Oksenhendler, E, et al.
Published: (2012)

EFFICIENCY OF IGG REPLACEMENT THERAPY IN PATIENTS WITH CVID: CORRELATIONS WITH CLINICAL PHENOTYPE AND POLYMORPHISM OF THE NEONATAL FC RECEPTOR
by: Oksenhendler, E, et al.
Published: (2012)

Immunoglobulin replacement therapy for primary immunodeficiencies.
by: Peter, J, et al.
Published: (2014)

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
by: Yanis Ramdani, et al.
Published: (2022-08-01)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
by: Christophe Dumet, et al.
Published: (2023-03-01)

The neonatal Fc receptor expression during macrophage differentiation is related to autophagy
by: Juliette Lamamy, et al.
Published: (2022-11-01)

“Ways in which the neonatal Fc-receptor is involved in autoimmunity”
by: Juliette Lamamy, et al.
Published: (2021-01-01)

Finding the Right Heavy Chains for Immunostimulatory Antibodies
by: Pierre Boulard, et al.
Published: (2022-09-01)

Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
by: Gilles Thibault, et al.
Published: (2021-06-01)

Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts
by: Chapel, H, et al.
Published: (2012)

Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts.
by: Chapel, H, et al.
Published: (2012)

Subcutaneous immunoglobulin replacement therapy: the European experience.
by: Chapel, H, et al.
Published: (2013)

Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?
by: Coco R. Beudeker, et al.
Published: (2022-10-01)

Immunoglobulin replacement therapy by self-infusion at home.
by: Chapel, H, et al.
Published: (1988)

Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy.
by: Bhole, M, et al.
Published: (2008)

Infection Outcomes in Relation to Immunoglobulin Therapy for Common Variable Immunodeficiency Disorders Over 22 Years
by: Lucas, M, et al.
Published: (2010)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.
by: Lucas, M, et al.
Published: (2010)

Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes
by: Rajiv Mallick, et al.
Published: (2022-12-01)

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
by: Bjorkander, J, et al.
Published: (2000)

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
by: Suzanne Skoda-Smith, et al.
Published: (2009-12-01)

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach
by: Jolles, S, et al.
Published: (2016)

European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries.
by: Quinti, I, et al.
Published: (2002)

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes.
by: Chapel, H, et al.
Published: (1994)

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.
by: Griffiths, H, et al.
Published: (1989)

The Neonatal Fc Receptor (FcRn): A Misnomer?
by: Michal Pyzik, et al.
Published: (2019-07-01)

Correction: The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells.
by: Sandeep Gupta, et al.
Published: (2013-11-01)

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
by: Remo Poto, et al.
Published: (2023-09-01)

Intravenous immunoglobulin therapy.
by: Chapel, H
Published: (1996)

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
by: Yusuke Mimura, et al.
Published: (2022-01-01)

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.
by: Chapel, H, et al.
Published: (2008)

Immunoglobulin Classification Based on FC* and GC* Features
by: Hao Wan, et al.
Published: (2022-01-01)

Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes
by: R. Mallick, et al.
Published: (2024-02-01)

Parameter Identification for a Model of Neonatal Fc Receptor-Mediated Recycling of Endogenous Immunoglobulin G in Humans
by: Felicity Kendrick, et al.
Published: (2019-04-01)

Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
by: Tamas Pongracz, et al.
Published: (2022-04-01)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
by: Diana Cadena Castaneda, et al.
Published: (2018-09-01)

Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011.
by: Chapel, H
Published: (2012)

Hepatitis C and intravenous immunoglobulin - Concluding remarks
by: Chapel, H
Published: (1996)

Fc receptors for immunoglobulins and their appearance during vertebrate evolution.
by: Srinivas Akula, et al.
Published: (2014-01-01)